Structural origin of selectivity in class II-selective histone deacetylase inhibitors

被引:106
作者
Estiu, Guillermina [1 ,2 ]
Greenberg, Edward [3 ,4 ]
Harrison, Christopher B. [1 ,2 ]
Kwiatkowski, Nicholas P. [3 ,4 ]
Mazitschek, Ralph [3 ,4 ]
Bradner, James E. [3 ,4 ]
Wiest, Olaf [1 ,2 ]
机构
[1] Univ Notre Dame, Walther Canc Res Ctr, Notre Dame, IN 46556 USA
[2] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA
[3] Harvard Univ, Broad Inst, Cambridge, MA 02142 USA
[4] MIT, Cambridge Ctr 7, Cambridge, MA 02142 USA
关键词
D O I
10.1021/jm7015254
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The development of class- and isoform-selective histone deacetylase (HDAC) inhibitors is highly desirable for the study of the complex interactions of these proteins central to transcription regulation as well as for the development of selective HDAC inhibitors as drugs in epigenetics. To provide a structural basis for the rational design of such inhibitors, a combined computational and experimental study of inhibition of three different histone deacetylase isoforms, HDAC1, -6, and -8, with three different hydroxamate inhibitors is reported. While SAHA was found to be unselective for the inhibition of class I and class II HDACs, the other inhibitors were found to be selective toward class II HDACs. Molecular dynamics simulations indicate that this selectivity is caused by both the overall shape of the protein surface leading to the active site and specific interactions of an aspartate residue in a polar loop and two phenylalanines and a methionine in a nonpolar loop. Monitoring the specific interactions as a function of the simulation time identifies a key sulfur-pi interaction. The implications of the structural motifs for the design of class II-selective HDAC inhibitors are discussed.
引用
收藏
页码:2898 / 2906
页数:9
相关论文
共 71 条
[31]  
LASKOWSKI RA, 1992, PROTEINS, V12, P345
[32]  
Lindemann RK, 2004, CELL CYCLE, V3, P779
[33]   Epigenetics and cancer [J].
Lund, AH ;
van Lohuizen, M .
GENES & DEVELOPMENT, 2004, 18 (19) :2315-2335
[34]   Histone deacetylase inhibitors in programmed cell death and cancer therapy [J].
Marks, PA ;
Jiang, XJ .
CELL CYCLE, 2005, 4 (04) :549-551
[35]   Comparative protein structure modeling of genes and genomes [J].
Martí-Renom, MA ;
Stuart, AC ;
Fiser, A ;
Sánchez, R ;
Melo, F ;
Sali, A .
ANNUAL REVIEW OF BIOPHYSICS AND BIOMOLECULAR STRUCTURE, 2000, 29 :291-325
[36]   RAPID COMPARISON OF PROTEIN STRUCTURES [J].
MCLACHLAN, AD .
ACTA CRYSTALLOGRAPHICA SECTION A, 1982, 38 (NOV) :871-873
[37]   Crystal structure of a bacterial class 2 histone deacetylase homologue [J].
Nielsen, TK ;
Hildmann, C ;
Dickmanns, A ;
Schwienhorst, A ;
Ficner, R .
JOURNAL OF MOLECULAR BIOLOGY, 2005, 354 (01) :107-120
[38]   Non-hydrogen bond interactions involving the methionine sulfur atom [J].
Pal, D ;
Chakrabarti, P .
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2001, 19 (01) :115-128
[39]   Class I histone deacetylase-selective novel synthetic inhibitors potently inhibit human tumor proliferation [J].
Park, JH ;
Jung, Y ;
Kim, TY ;
Kim, SG ;
Jong, HS ;
Lee, JW ;
Kim, DK ;
Lee, JS ;
Kim, NK ;
Kim, TY ;
Bang, YJ .
CLINICAL CANCER RESEARCH, 2004, 10 (15) :5271-5281
[40]   AMBER, A PACKAGE OF COMPUTER-PROGRAMS FOR APPLYING MOLECULAR MECHANICS, NORMAL-MODE ANALYSIS, MOLECULAR-DYNAMICS AND FREE-ENERGY CALCULATIONS TO SIMULATE THE STRUCTURAL AND ENERGETIC PROPERTIES OF MOLECULES [J].
PEARLMAN, DA ;
CASE, DA ;
CALDWELL, JW ;
ROSS, WS ;
CHEATHAM, TE ;
DEBOLT, S ;
FERGUSON, D ;
SEIBEL, G ;
KOLLMAN, P .
COMPUTER PHYSICS COMMUNICATIONS, 1995, 91 (1-3) :1-41